David L. Herzog - 14 Mar 2023 Form 4 Insider Report for METLIFE INC (MET)

Role
Director
Signature
/s/ Anna Nazarenko, Authorized Signer
Issuer symbol
MET
Transactions as of
14 Mar 2023
Net transactions value
+$2,835
Form type
4
Filing time
16 Mar 2023, 16:34:56 UTC
Previous filing
02 Mar 2023
Next filing
04 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Award $2,835 +48 +0.24% $59.07 20,348 14 Mar 2023 Direct F1
holding MET Common Stock 87 14 Mar 2023 by David L. Herzog Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.